Details for Patent: 6,960,577
✉ Email this page to a colleague
Summary for Patent: 6,960,577
Title: | Combination therapy for treatment of refractory depression |
Abstract: | Methods for treating a patient suffering from or susceptible to treatment resistant major depression comprising administering olanzapine and fluoxetine are disclosed. |
Inventor(s): | Tollefson; Gary Dennis (Indianapolis, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 10/144,159 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,960,577
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,960,577
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 4008699 | ⤷ Sign Up | |||
Australia | 761510 | ⤷ Sign Up | |||
Brazil | 9911049 | ⤷ Sign Up | |||
Canada | 2332814 | ⤷ Sign Up | |||
China | 1154496 | ⤷ Sign Up | |||
China | 1311681 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |